Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sensitivity and Specificity × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6 Lymphoid 4 Thoracic 1 Plasma cell 1 Gastrointestinal 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 59 Cyclophosphamide 39 Bortezomib 33 Melphalan 22 Lenalidomide 20 Thalidomide 16 pomalidomide 14 daratumumab 12 fludarabine 11 carfilzomib 7 Filgrastim 7 Doxorubicin 6 Busulfan 6 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Calcium Dobesilate 5 Bendamustine Hydrochloride 5 ixazomib 4 fludarabine phosphate 4 Surveys and Questionnaires 4 Mycophenolic Acid 4 Clarithromycin 4 selinexor 3 sargramostim 3 liposomal doxorubicin 3 isatuximab 3 dexamethasone acetate 3 Radiotherapy 3 Neoadjuvant Therapy 3 Methylprednisolone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01886976 2016-01-28

CART-138

Chinese PLA General Hospital

Phase 1/2 Unknown

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡